Characteristics of patients undergoing lung transplantation
| Characteristic . | Median (range) or N (%) . |
|---|---|
| BMI | 15.2 (10.1-25.8) |
| PCO2 | 59.5 (34.0-115.0) |
| Hugh-Jones∗ | |
| 2-3 | 2 (4) |
| 4 | 14 (31) |
| 5 | 29 (64) |
| Oxygen | |
| Nasal/mask | 30 (67) |
| NPPV | 9 (20) |
| Intubated | 6 (13) |
| Pneumothorax | |
| Yes | 29 (64) |
| No | 16 (36) |
| Respiratory failure | |
| Obstructive | 11 (24) |
| Restrictive | 14 (31) |
| Mixed | 20 (44) |
| Corticosteroids | |
| None | 13 (29) |
| 2.5-10 mg PSL | 16 (36) |
| 12.5-30 mg PSL | 16 (36) |
| Immunosuppressants | |
| None | 34 (76) |
| Calcineurin inhibitors | 9 (20) |
| MMF | 2 (4) |
| Chronic GVHD in other organs | |
| None | 36 (80) |
| Skin | 5 (9) |
| Eye | 1 (2) |
| Skin/oral/eye | 3 (7) |
| Concomitant infection | |
| Aspergillosis | 4 (9) |
| NTM | 3 (7) |
| None | 38 (84) |
| Donors for lung transplantation | |
| Living | 36 (80) |
| Brain-dead | 9 (20) |
| Characteristic . | Median (range) or N (%) . |
|---|---|
| BMI | 15.2 (10.1-25.8) |
| PCO2 | 59.5 (34.0-115.0) |
| Hugh-Jones∗ | |
| 2-3 | 2 (4) |
| 4 | 14 (31) |
| 5 | 29 (64) |
| Oxygen | |
| Nasal/mask | 30 (67) |
| NPPV | 9 (20) |
| Intubated | 6 (13) |
| Pneumothorax | |
| Yes | 29 (64) |
| No | 16 (36) |
| Respiratory failure | |
| Obstructive | 11 (24) |
| Restrictive | 14 (31) |
| Mixed | 20 (44) |
| Corticosteroids | |
| None | 13 (29) |
| 2.5-10 mg PSL | 16 (36) |
| 12.5-30 mg PSL | 16 (36) |
| Immunosuppressants | |
| None | 34 (76) |
| Calcineurin inhibitors | 9 (20) |
| MMF | 2 (4) |
| Chronic GVHD in other organs | |
| None | 36 (80) |
| Skin | 5 (9) |
| Eye | 1 (2) |
| Skin/oral/eye | 3 (7) |
| Concomitant infection | |
| Aspergillosis | 4 (9) |
| NTM | 3 (7) |
| None | 38 (84) |
| Donors for lung transplantation | |
| Living | 36 (80) |
| Brain-dead | 9 (20) |
BMI, body mass index; MMF, mycophenolate mofetil; NPPV, noninvasive positive pressure ventilation; NTM, nontuberculous mycobacteriosis; PCO2, partial pressure of carbon dioxide; PSL, prednisolone.
Hugh-Jones: 1, able to perform exertion and walk upstairs as well as a healthy person of the same age; 2, able to walk as well as a healthy person of the same age but unable to walk upstairs as well as a healthy person; 3, unable to walk as fast as a healthy person on level ground but able to walk 1 mile at own pace; 4, unable to walk 50 yards without resting; and 5, shortness of breath during conversation, and dressing and undressing, and unable to go out due to shortness of breath.